$70,000 of ALIGNMENT HEALTHCARE INC. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Advocacy regarding deregulation and Medicare rules."
You can find more data on corporate lobbying on Quiver Quantitative.
ALHC Insider Trading Activity
ALHC insiders have traded $ALHC stock on the open market 38 times in the past 6 months. Of those trades, 1 have been purchases and 37 have been sales.
Here’s a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:
- JOHN E KAO (Chief Executive Officer) has made 0 purchases and 13 sales selling 1,445,945 shares for an estimated $27,627,314.
- DAWN CHRISTINE MARONEY (President) has made 0 purchases and 10 sales selling 245,862 shares for an estimated $4,676,584.
- ANDREAS P. WAGNER (Chief Human Resources Officer) has made 0 purchases and 4 sales selling 66,958 shares for an estimated $1,273,939.
- HYONG KIM (Chief Medical Officer) has made 0 purchases and 2 sales selling 54,355 shares for an estimated $1,042,274.
- CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer) has made 0 purchases and 2 sales selling 43,138 shares for an estimated $768,722.
- JOSEPH S KONOWIECKI (EVP, Corporate Affairs) sold 25,000 shares for an estimated $600,000
- SEBASTIAN BURZACCHI (COO - Mgmt Services Org) sold 15,361 shares for an estimated $274,040
- ROBERT L. SCAVO (Chief Information Officer) has made 0 purchases and 3 sales selling 15,329 shares for an estimated $271,878.
- JAMES M HEAD (Chief Financial Officer) sold 11,100 shares for an estimated $233,987
- MARK D. KENT (President - MSO) purchased 14,848 shares for an estimated $197,626
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ALHC Hedge Fund Activity
We have seen 163 institutional investors add shares of ALHC stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GENERAL ATLANTIC, L.P. removed 13,167,733 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $232,015,455
- CAPITAL RESEARCH GLOBAL INVESTORS added 3,593,576 shares (+inf%) to their portfolio in Q1 2026, for an estimated $63,318,809
- WELLINGTON MANAGEMENT GROUP LLP added 3,028,043 shares (+21.5%) to their portfolio in Q1 2026, for an estimated $53,354,117
- BANK OF NEW YORK MELLON CORP added 2,316,777 shares (+232.5%) to their portfolio in Q1 2026, for an estimated $40,821,610
- BANK OF AMERICA CORP /DE/ added 1,961,778 shares (+156.5%) to their portfolio in Q1 2026, for an estimated $34,566,528
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC added 1,805,752 shares (+276.7%) to their portfolio in Q1 2026, for an estimated $31,817,350
- MILLENNIUM MANAGEMENT LLC added 1,270,954 shares (+49.5%) to their portfolio in Q1 2026, for an estimated $22,394,209
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ALHC Price Targets
Multiple analysts have issued price targets for $ALHC recently. We have seen 4 analysts offer price targets for $ALHC in the last 6 months, with a median target of $23.5.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $16.0 on 05/26/2026
- Jonathan Yong from UBS set a target price of $22.0 on 05/01/2026
- John Stansel from JP Morgan set a target price of $26.0 on 02/05/2026
- Ryan Langston from TD Cowen set a target price of $25.0 on 01/16/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
